Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Leuprolide effectively reduces hair growth in hirsute women at higher doses.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Recombinant gonadotropins improve future fertility in CHH patients.

Hirsutism is managed by assessing testosterone levels and using oral contraceptives, with ethical considerations on treatment access.

Treat hirsutism in premenopausal women with oral contraceptives and consider additional treatments if needed.

Medroxyprogesterone acetate injections are more effective than topical ointment in treating excessive hair growth in women.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Distal hair cortisol is not a reliable measure of early pregnancy cortisol levels.

The oral contraceptive alone is the preferred treatment for hirsutism, as adding the GnRH analog showed no significant benefit.

Choosing the right starting dose of Clomiphene Citrate for ovulation induction in PCOS women is challenging; higher BMI and hormone levels may indicate resistance to the standard dose.

Cross-sex hormone therapy is important for managing gender dysphoria and requires careful monitoring and healthcare provider education.

Cyproterone acetate at 2mg daily is as effective as higher doses for treating excessive hair growth in women.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Both finasteride and GnRH agonist treatments reduced hair growth in women with idiopathic hirsutism, but GnRH agonist was more effective.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

Short-acting testosterone injections in a clinic are a preferred treatment for low testosterone because they work well, are convenient, and patients stick with the treatment.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Cyproterone acetate is effective for treating hirsutism and acne but less so for hair loss, with side effects similar to birth control pills.

The method accurately measures cyproterone acetate in plasma, showing no significant difference between two formulations.

Nafarelin may effectively treat excessive hair growth in women by reducing certain hormone levels.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Combination therapy significantly reduces testosterone and moderately reduces hair growth in women with hirsutism.

Glucocorticoid treatment lowered androgen levels but didn't improve hirsutism or ovulation and caused weight gain.

Cyproterone acetate and ethinylestradiol significantly lowered AMH levels in PCOS patients resistant to clomiphene.